It’s been a difficult quarter for the biotech sector, with economies struggling to recover from high inflation making for a small appetite for risk. The ASX.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson speaks with Proactive after the successful completion of enrolment for the company’s early.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has successfully completed enrolment for its Early Feasibility Study (EFS), approved by the US Food and Drug.
In 2023, the healthcare sector faced challenges in keeping pace with the broader equity market. However, Janus Henderson portfolio managers Andy Acker and.
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has received $1.4 million in tax rebate incentives under the Australian Government’s Research and Development.